Navigation Links
Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data
Date:5/9/2011

;

DIFICID™ (fidaxomicin), if approved, will be the first new antibiotic for the treatment of Clostridium difficile infection (CDI) in nearly 30 years. In two Phase 3 trials for the treatment of CDI, fidaxomicin was non-inferior in clinical cure when compared to vancomycin, the only FDA approved product for CDI.  DIFICID also demonstrated superiority to vancomycin in global cure, which is defined as a cure without recurrence, or a sustained cure, through the end of the follow up period. This difference was driven by DIFICID's lower rates of relapse of diarrhea following cessation of the CDI treatment.

About Clostridium difficile Infection (CDI)

Clostridium difficile infection (CDI), commonly referred to as "C. difficile" or "c-diff", has become a significant medical problem in hospitals, long-term care facilities, and in the community and is estimated to afflict more than 700,000 people each year in the U.S.  It is a serious illness resulting from infection of the inner lining of the colon by C. difficile bacteria, which produce toxins that cause inflammation of the colon, severe diarrhea and, in the most serious cases, death.  Patients typically develop CDI from the use of broad-spectrum antibiotics that disrupt normal gastrointestinal (gut) flora, thus allowing C. difficile bacteria to flourish and produce toxins.

Current therapeutic options for CDI include the off-label use of metronidazole and oral vancomycin, the latter being the only FDA-approved treatment.  However, approximately 20% to 30% of CDI patients who initially respond to these treatments experience a clinical recurrence, defined as a relapse or re-establishment of diarrhea, following cessation of the CDI treatment.

Primary risk factors for CDI include broad-spectrum antibiotic use (such as cephalosporins and fluoroquinolones), older age (over 65) and exposure to emerging hyper-virulent strains (BI/
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rhythmia Medical Highlights Studies to be Presented at Heart Rhythm Society 2011 Annual Scientific Session
2. ConvaTec Supported Studies to be Presented at the 24th Annual Symposium on Advanced Wound Care (SAWC) and Wound Healing Society (WHS)
3. New Study Results Presented on Dexlansoprazole and Lansoprazole Effects on Plavix® (clopidogrel bisulfate)
4. Three Studies Presented at the 2011 SHEA Annual Scientific Meeting Show That the ICU Medical MicroCLAVE® Contributes to a Significant Decrease in Bacterial Transfer and Reduction in Bloodstream Infections
5. REMEDIAL II Results on PLC Systems RenalGuard® to be Presented at ACC 2011s Late Breaking Clinical Trial Session
6. Long-Term Data on QNEXA® to be Presented at The American College of Cardiology Annual Meeting
7. Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting
8. Advancements in GYN Oncology; Instrumentation and Techniques to be Presented by Nicholas C. Lambrou, M.D. of Miami
9. Urocidin™ Phase III Clinical Trial Results to be Presented at EAU and AUA Conferences
10. New England Patriots Offensive Line Wins Second Annual Madden Most Valuable Protectors Award Presented by Prilosec OTC®
11. New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 30, 2014  Today the US Surgeon General issued the ... tanning or sun burns stating they can lead directly to ... Boris Lushniak , says that "skin cancer is a major ... much exposure to indoor and outdoor ultraviolet light is a ... Medicine, in Boca Raton, Florida , ...
(Date:7/30/2014)... Reportlinker.com announces that a new market ... mHealth and Home Monitoring – 6th Edition ... Executive summary mHealth can revolutionize how ... decreased costs and improved sustainability of the healthcare ... in an early stage, but on the brink ...
(Date:7/30/2014)... N.J. , July 30, 2014 Stryker brand ambassadors ... this week at the 3M Championship Champions Tour event near ... Cities, in Blaine . Stryker is the official ... Starting Friday, August 1 st through Sunday, ... Stryker Mobility Zone; an on-site joint health destination located in the ...
Breaking Medicine Technology:Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2mHealth and Home Monitoring - 6th Edition 2mHealth and Home Monitoring - 6th Edition 3mHealth and Home Monitoring - 6th Edition 4mHealth and Home Monitoring - 6th Edition 5mHealth and Home Monitoring - 6th Edition 6mHealth and Home Monitoring - 6th Edition 7mHealth and Home Monitoring - 6th Edition 8mHealth and Home Monitoring - 6th Edition 9mHealth and Home Monitoring - 6th Edition 10mHealth and Home Monitoring - 6th Edition 11Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5
... Masimo (NASDAQ: MASI ) announced today ... for the period ended December 31, 2011, after the market closes ... will begin at 1:30 p.m. PT (4:30 p.m. ET) and will ... Mark P. de Raad, Executive Vice President and Chief Financial Officer. ...
... NEW YORK, Jan. 26, 2012 Dr. Ira J. Haimowitz, ... CementBloc, will be a featured presenter at the eMarketing University ... New York City on February 6, 2012. The ... product management seeking to incorporate digital tactics into their marketing ...
Cached Medicine Technology:Masimo to Report Fourth Quarter and Full Year 2011 Financial Results After Market Close on February 14, 2012 2Masimo to Report Fourth Quarter and Full Year 2011 Financial Results After Market Close on February 14, 2012 3Ira Haimowitz, PhD, EVP, at The CementBloc, to Present on Best Practices in iPad Interactive Selling at 11th Annual ePharma Summit™ 2
(Date:7/31/2014)... Nashville, TN (PRWEB) July 31, 2014 ... a pipeline partner with the National Rural Health Association ... commitment by ProtonPACS to understanding the needs of rural ... with the National Rural Health Association,” said Dr. Mark ... share the many advantages of ProtonPACS, we are also ...
(Date:7/31/2014)... 2014) While it is known that members of the ... a new study finds that female enlistees and female ... civilian counterparts. This study was published today in ... on behalf of the Inter-University Seminar on Armed Forces ... Tedrow studied surveys of nearly 9,000 men and women ...
(Date:7/31/2014)... Staying happy in a relationship and loving for years ... get sucked into the logistical ruts they know as their ... kids. , That’s why Couples in Trouble Relationship Expert, ... to Reignite the Spark in Your Marriage TODAY” Guide as ... much better path to happiness, and a far less costly ...
(Date:7/31/2014)... According to new research report "Meat Substitutes ... (Tofu, Tofu-Based Product, Tempeh, TVP, Seitan, Quorn, Others), ... Forecasts to 2019", defines and segments the global ... of the market value of sources, types, and ... the driving and restraining factors for the global ...
(Date:7/31/2014)... Eden Lew has been awarded the ... Technologies" Scholarship through EDSF (Electronic Document ... the contributions Chuck Forman made throughout his career ... his battle with cancer on October 2, 2013. ... thrilled to see her receive the second annual ...
Breaking Medicine News(10 mins):Health News:ProtonPACS Announces Pipeline Partnership with the National Rural Health Association. 2Health News:Women in military less likely to drink than civilian women 2Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 2Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 3Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 2Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 3Health News:Eden Lew Recipient of 2014 EDSF Scholarship Honoring Chuck Forman 2Health News:Eden Lew Recipient of 2014 EDSF Scholarship Honoring Chuck Forman 3
... Consumer protection group,s new resource helps Americans cut prescription ... , WASHINGTON, Dec. 1 A collection ... to consumers to help fend off the dangers of ... Partnership for Safe Medicines, "Consumer Resources" is designed to ...
... Indicated for the Treatment of Both Moderate to Severe Vaginal Dryness ... Due to Menopause , , ... , MONTVALE, N.J., Dec. 1 Barr ... U.S. Food and Drug Administration (FDA) has approved its subsidiary Duramed ...
... found in disorder, study says , , MONDAY, Dec. ... process sounds a fraction of a second slower than ... and language issues linked to the condition, a new ... which records minute magnetic fields associated with electrical brain ...
... lesson from 2 failed trials: The science must be more vigorous, ... HIV would give up without a fight. , As World AIDS ... at what went wrong in recent, high-profile failures of two human ... is still very possible, and with it comes the ...
... Decision Resources, one of the,world,s leading research and advisory ... share for GlaxoSmithKline,s Advair is,declining in all lines of ... The new report entitled Treatment ... first-, second- and third-lines of therapy to 12.2 percent,13.6 ...
... the international generic pharmaceuticals company, today announced that it ... Administration to market Bupropion Hydrochloride extended-release tablets (XL) 150mg. ... , , Bupropion Hydrochloride ... are the generic equivalent of Wellbutrin XL(R) for the ...
Cached Medicine News:Health News:Partnership for Safe Medicines Arms Public Against Counterfeit Drugs 2Health News:Partnership for Safe Medicines Arms Public Against Counterfeit Drugs 3Health News:Partnership for Safe Medicines Arms Public Against Counterfeit Drugs 4Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 2Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 3Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 4Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 5Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 6Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 7Health News:Scans Show Sound-Processing Deficits in Autistic Kids 2Health News:Hopes for AIDS Vaccine Still Alive Despite Setbacks 2Health News:Hopes for AIDS Vaccine Still Alive Despite Setbacks 3Health News:Hopes for AIDS Vaccine Still Alive Despite Setbacks 4Health News:Advair's Patient Share in Newly Diagnosed Asthma Patients is Declining 2Health News:Actavis Receives Approval of Generic Wellbutrin XL(R) 150mg in the U.S. 2
The Prostar XL 8 is a suture mediated closure system. It can be used with 8F sheath. It has two 3-0 braided polyester sutures and also has the safety of guidewire....
... vascular closure device quickly seals ... procedures, allowing for early ambulation ... creates a mechanical seal by ... bio-absorbable anchor and collagen sponge, ...
Terumo's Optitorque offers superior torque and precision control. It's patient-friendly, high torque design makes it the catheter of choice for demanding angiography....
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Medicine Products: